| Literature DB >> 29616213 |
Lina A Basal1, Matthew J Allen1.
Abstract
Considerable research effort has focused on the in vivo use of responsive imaging probes that change imaging properties upon reacting with oxygen because hypoxia is relevant to diagnosing, treating, and monitoring diseases. One promising class of compounds for oxygen-responsive imaging is EuII-containing complexes because the EuII/III redox couple enables imaging with multiple modalities including magnetic resonance and photoacoustic imaging. The use of EuII requires care in handling to avoid unintended oxidation during synthesis and characterization. This review describes recent advances in the field of imaging agents based on discrete EuII-containing complexes with specific focus on the synthesis, characterization, and handling of aqueous EuII-containing complexes.Entities:
Keywords: chelating ligands; contrast agents; coordination chemistry; divalent europium; lanthanides; molecular imaging probes
Year: 2018 PMID: 29616213 PMCID: PMC5867344 DOI: 10.3389/fchem.2018.00065
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Pathway for EuII-containing complexes that have applications in molecular imaging.
Figure 2Ligands used with EuII and the techniques described in the synthesis section of this manuscript.
Figure 3Reported strategies to form the EuII-containing complexes included in this manuscript.
Figure 4Cartoon cyclic voltammograms of (A) a solution of in water, (B) a solution of ligand L in water, and (C) a solution of both and L in water. The new peak in (C) relative to (A) is indicative of the in-situ formation of the Eu-containing complex EuL.
Figure 5Diagram for the characterization of EuII-containing complexes.
Midpoint potentials of EuII/III-containing complexes more negative than aqua ions.
| −1.417 | −1.373 | saturated calomel | 4 | Botta et al., | |
| −1.386 | −1.342 | saturated calomel | 4 | Botta et al., | |
| −1.375 | −1.331 | saturated calomel | 4 | Botta et al., | |
| −1.356 | −1.356 | Ag/AgCl | 6.5 | Gál et al., | |
| −1.356 | −1.312 | saturated calomel | 4 | Botta et al., | |
| −1.35 | −1.35 | Ag/AgCl | nr | Burai et al., | |
| −1.331 | −1.331 | Ag/AgCl | 6.5 | Gál et al., | |
| −1.291 | −1.291 | Ag/AgCl | 6.5 | Gál et al., | |
| −1.241 | −1.241 | Ag/AgCl | 6.5 | Gál et al., | |
| −1.18 | −1.18 | Ag/AgCl | 7 | Vanek et al., | |
| −1.164 | −1.120 | saturated calomel | 4 | Botta et al., | |
| −1.153 | −1.109 | saturated calomel | 4 | Botta et al., | |
| −1.135 | −1.135 | Ag/AgCl | nr | Burai et al., | |
| −1.125 | −1.081 | Saturated calomel | 4 | Botta et al., | |
| −1.1105 | −1.1105 | Ag/AgCl | 7 | Burnett et al., | |
| −1.0680 | −1.0680 | Ag/AgCl | 7 | Burnett et al., | |
| −1.052 | −1.052 | Ag/AgCl | 6.5 | Gál et al., | |
| −0.996 | −0.996 | Ag/AgCl | nr | Burai et al., | |
| −0.9710 | −0.9710 | Ag/AgCl | 7 | Burnett et al., | |
| −0.92 | −0.92 | Ag/AgCl | nr | Burai et al., | |
| −0.903 | −0.903 | Ag/AgCl | 7 | Ekanger et al., | |
| −0.879 | −0.879 | Ag/AgCl | 4 | Ekanger et al., | |
| −0.82 | −0.82 | Ag/AgCl | nr | Burai et al., | |
| −0.817 | −0.817 | Ag/AgCl | 6.5 | Gál et al., | |
| −0.753 | −0.753 | Ag/AgCl | 7 | Regueiro-Figueroa et al., | |
| −0.727 | −0.727 | Ag/AgCl | na | Basal et al., | |
| −0.720 | −0.720 | Ag/AgCl | na | Basal et al., |
converted to V vs. Ag/AgCl by subtracting 0.044 V from the saturated calomel values (Bard and Faulkner, ;
nr, not reported;
na, not applicable, solvent is dimethylformamide.
Midpoint potentials of EuII/III-containing aqua complexes and complexes more positive than aqua ions.
| aqua | −0.67 | −0.67 | Ag/AgCl | 6.5 | Gál et al., |
| aqua | −0.668 | −0.624 | saturated calomel | 4 | Botta et al., |
| aqua | −0.664 | −0.620 | saturated calomel | 3 | Yee et al., |
| aqua | −0.648 | −0.648 | Ag/AgCl | na | Basal et al., |
| aqua | −0.6365 | −0.6365 | Ag/AgCl | 7 | Burnett et al., |
| aqua | −0.63 | −0.63 | Ag/AgCl | nr | Burai et al., |
| −0.61 | −0.61 | Ag/AgCl | 7 | Regueiro-Figueroa et al., | |
| aqua | −0.585 | −0.585 | Ag/AgCl | nr | Burai et al., |
| aqua | −0.554 | −0.554 | Ag/AgCl | 2.08 | Anderson and Macero, |
| aqua | −0.549 | −0.7645 | Fc/Fc+ | 7.5 | Gamage et al., |
| −0.479 | −0.435 | saturated calomel | 2–7 | Yee et al., | |
| −0.453 | −0.453 | Ag/AgCl | 7 | Regueiro-Figueroa et al., | |
| −0.41 | −0.37 | saturated calomel | nr | Yee et al., | |
| −0.259 | −0.215 | saturated calomel | nr | Yee et al., | |
| −0.141 | −0.3669 | Fc/Fc+ | 7.5 | Gamage et al., | |
| [P5W30O110]15− | 0.11 | 0.11 | Ag/AgCl | 0 | Antonio and Soderholm, |
| −0.100 | −0.2996 | Fc/Fc+ | 7.5 | Gamage et al., | |
| −0.068 | −0.2769 | Fc/Fc+ | 7.5 | Gamage et al., | |
| 0.016 | −0.2324 | Fc/Fc+ | 7.5 | Gamage et al., | |
| 0.083 | −0.2123 | Fc/Fc+ | 7.5 | Gamage et al., | |
| 0.13 | 0.13 | Ag/AgCl | 9.7 | Kuda-Wedagedara et al., |
converted to V vs. Ag/AgCl by subtracting 0.044 V from the saturated calomel values (Bard and Faulkner, ;
average of the anodic and cathodic peak potentials;
Fc/Fc;
na, not applicable, solvent is dimethylformamide;
nr, not reported.
Figure 6Diagram describing techniques that can be used to analyze EuII-containing complexes with air-free conditions.
Figure 7Pictures of apparatuses included in the handling section of this manuscript: (A) empty tube holder (top) and tube holder with tubes that are covered in wax (bottom); (B) jar sealed with electrical tape that contains glass wool and syringes of EuII-containing complexes packed under an inert atmosphere and (inset) a plastic 1 mL syringe with a rubber tip on the plunger that contains a solution of a EuII-containing complex; (C) wax-sealed cuvette; (D) electrical-tape-sealed cuvette; (E) wax-sealed NMR tube; (F) electrical-tape-sealed NMR tube; (G) J-young NMR tube (left) and flame-sealed NMR tube (right); (H) electrical-tape-sealed vial containing a solid sample; and (I) glass vial that contains solid sample covered with a tissue that is secured with a rubber band. All scale bars represent 1 cm.